Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,776 | -21,617 | -15,925 | -14,337 | -17,480 |
| Depreciation Amortization | 383 | 341 | 349 | 245 | 45 |
| Accounts payable and accrued liabilities | -1,354 | 960 | -899 | -143 | 2,012 |
| Other Working Capital | 4,907 | 630 | -196 | 144 | 1,287 |
| Other Operating Activity | 1,271 | -848 | 1,173 | 1,390 | 6,750 |
| Operating Cash Flow | $-32,569 | $-20,534 | $-15,498 | $-12,701 | $-7,386 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -32,726 | -65,270 | N/A | 329 | N/A |
| PPE Investments | -156 | -26 | -7 | -1,342 | -1,302 |
| Investing Cash Flow | $-32,882 | $-65,296 | $-7 | $-1,013 | $-1,302 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 54,803 | 47,644 | 263 | 61 | 63,030 |
| Other Financing Activity | 0 | 122 | 59 | 0 | 15,245 |
| Financing Cash Flow | $54,803 | $47,766 | $322 | $61 | $78,275 |
| Beginning Cash Position | 12,027 | 50,091 | 65,274 | 78,927 | 9,340 |
| End Cash Position | 1,379 | 12,027 | 50,091 | 65,274 | 78,927 |
| Net Cash Flow | $-10,648 | $-38,064 | $-15,183 | $-13,653 | $69,587 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,569 | -20,534 | -15,498 | -12,701 | -7,386 |
| Capital Expenditure | -156 | -26 | -7 | -1,342 | -1,302 |
| Free Cash Flow | -32,725 | -20,560 | -15,505 | -14,043 | -8,688 |